Solid Biosciences
SLDB
6.68
-0.17
-2.48%
Solid Biosciences
US · SLDB
#3476 by market cap
Listed 2018
6.68
-0.17
-2.48%
Live - 5344 symbols - heartbeat 429s ago
· 2026-10-08 10:00
Pre-market
6.76
-1.31%
After-hours
6.85
0.00%
Overnight
6.87
+0.29%
- Market cap
- 716.26M
- P/E (TTM)i
- -3.53
- P/Bi
- 1.91
- EPSi
- -1.99
- Div yieldi
- 0.00%
- 52W posi
- 38%
Reader sentiment
Are you bullish or bearish on SLDB?
Anonymous reader poll. Unscientific, not investment advice.
About Solid Biosciences
Solid Biosciences, Inc. is a life science company, which engages in the development of treatments for patients with Duchenne muscular dystrophy. It also focuses on developing treatments for neuromuscular and cardiac diseases. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Charlestown, MA.
- Founded
- 2013
- CEO
- Mr. Alexander G. Cumbo
- Employees
- 121
- Headquarters
- Charlestown, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- solidbio.com
Company profile
- Exchange
- US
- Symbol
- SLDB
- Market-cap rank
- #3476
- Listing date
- 2018-01-25
- Market cap
- 716.26M
- Float cap
- 432.94M
- Shares out
- 107.23M
- Float shares
- 64.81M
Sectors & themes
Quote time 2026-10-08 10:00:30 · For reference only, not investment advice and not tailored to your situation.